WEST PHARMACEUTICAL SERVICES (WST)

West to Participate in Upcoming Investor Conference

/PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced...

WST Stock Earnings: West Pharmaceutical Servs Beats EPS, Beats Revenue for Q1 2024

WST stock results show that West Pharmaceutical Servs beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

West Announces First-Quarter 2024 Results and Declares Third-Quarter 2024 Dividend

/PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the first-quarter 2024 and updated full-year 2024...

Noteworthy Friday Option Activity: WST, ATGE, VKTX

West to Host First-Quarter 2024 Conference Call

/PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced...

Mettler-Toledo International Takes Over #284 Spot From West Pharmaceutical Services

Friday Sector Laggards: Technology & Communications, Healthcare

3 Pharma Stocks to Sell in March Before They Crash & Burn

Discover top pharma stocks to sell in March before they plummet. Learn why ACAD, AMLX and WST are on the list for urgent sell-off decisions.

May 17th Options Now Available For West Pharmaceutical Services (WST)

West to Participate in Upcoming Investor Conferences

/PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced...

West Pharmaceutical declares $0.20 dividend (NYSE:WST)

West Pharmaceutical (WST) declares $0.20/share quarterly dividend, in line with previous. Forward yield 0.22% Payable May 1; for shareholders of record April 24

West Announces Second-Quarter 2024 Dividend

/PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announced today...

West Pharmaceutical's 2024 Outlook Cautious, Analysts Remain Optimistic

West Pharmaceutical Services reports Q4 2023 adjusted EPS at $1.83, surpassing consensus. Quarterly sales hit $732 million missing estimates. 2024 guidance hints at moderated organic growth, emphasizing inventory management strategies.

Noteworthy Thursday Option Activity: WST, LULU, UPS

S&P 500 Movers: WST, ZBRA

West Announces Fourth-Quarter and Full-Year 2023 Results

/PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the fourth-quarter and full-year 2023 and introduced...

Tudor Investment exits Airbnb, Adobe; boosts Nvidia, Splunk (NYSE:WST)

Tudor Investment Corp. has started new equity positions in Exxon Mobil, Bristol-Myers Squibb, Crown Castle, and Expedia Group, according to its latest 13F...

Contract research firms gain after Q4 results (NYSE:IQV)

Shares of contract research organizations IQVIA Holdings (IQV) and Charles River Laboratories (CRL) gain as their Q4 results exceed expectations. Read more here.

West Named to Newsweek's America's Greatest Workplaces 2024 for Diversity

/PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announced today...

West to Host Fourth-Quarter and Full-Year 2023 Conference Call

/PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced...

Coupang Larger Than S&P 500 Component West Pharmaceutical Services

Commit To Buy West Pharmaceutical Services At $300, Earn 4% Using Options